Search Result "trinitrobenzenesulfonic acid"
LYS70 of E. coli Quinolinate Phosphoribosyltransferase Is Protected from Chemical Modification by Formation of an Inhibitor Complex.
Journal: Protein & Peptide Letters
Volume: 13 Issue: 2 Year: 2006 Page: 163-167
Author(s): Rajula Gaur, Tanesha Roberts, Kim Calvo
Milk Fermented with a 15-Lipoxygenase-1-Producing Lactococcus Lactis Alleviates Symptoms of colitis in a Murine Model
Journal: Current Pharmaceutical Biotechnology
Volume: 16 Issue: 5 Year: 2015 Page: 424-429
Author(s): Tessalia D.L. Saraiva,Katia Morais,Vanessa B. Pereira,Marcela de Azevedo,Clarissa S. Rocha,Camila C. Prosperi,Ana C. Gomes-Santos,Luis Bermudez-Humaran,Ana M.C. Faria,Herve M. Blottiere,Philippe Langella,Anderson Miyoshi,Alejandra de Moreno de LeBlanc,Jean G. LeBlanc,Vasco Azevedo
Advances in Anti-inflammatory Activity, Mechanism and TherapeuticApplication of Ursolic Acid
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 3 Year: 2022 Page: 422-436
Author(s): Mingzhu Luan,Huiyun Wang,Jiazhen Wang,Xiaofan Zhang,Fenglan Zhao,Zongliang Liu,Qingguo Meng
Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector
Journal: Current Gene Therapy
Volume: 19 Issue: 4 Year: 2019 Page: 274-287
Author(s): Sharwari Ghodke,Prajakta Mahajan,Kritika Gupta,Chilukuri Ver Avadhani,Prajakta Dandekar,Ratnesh Jain
Tachykinins as Therapeutic Targets in Inflammation
Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2 Issue: 1 Year: 2003 Page: 19-27
Author(s): M. Bhatia
Copaiba Oil Decreases Oxidative Stress and Inflammation But not Colon Damage in Rats with TNBS-Induced Colitis
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18 Issue: 3 Year: 2018 Page: 268-280
Author(s): Maiara M.C. Barbosa,Fernando A. Vicentini,Cristiane V. Castro-Ghizoni,Osmar A. Lameira,Anacharis B. Sa-Nakanishi,Livia Bracht,Rosane M. Peralta,Maria R.M. Natali,Adelar Bracht,Jurandir F. Comar
Recent Updates on the Therapeutics Benefits, Clinical Trials, and NovelDelivery Systems of Chlorogenic Acid for the Management of Diseases with aSpecial Emphasis on Ulcerative Colitis
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 6 Year: 2024 Page: 420-439
Author(s):
Mechanisms Involved in the Anti-Inflammatory Properties of Native and Genetically Engineered Lactic Acid Bacteria
Journal: Anti-Infective Agents
Volume: 11 Issue: 1 Year: 2013 Page: 60-70
Author(s): Jean G. LeBlanc,Silvina del Carmen,Meritxell Z. Turk,Fernanda A. Lima,Daniela S. Pontes,Anderson Miyoshi,Vasco Azevedo,Alejandra de Moreno de LeBlanc
Effect of Fibrin-binding Synthetic Oligopeptide on the Healing of Full-thickness Skin Wounds in Streptozotocin-induced Diabetic Rats
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 7 Year: 2013 Page: 1321-1328
Author(s): Jae-Eun Chung,Yun-Jeong Kim,Yoon-Jeong Park,Ki-Tae Koo,Yang-Jo Seol,Yong-Moo Lee,In-Chul Rhyu,Young Ku
Peroxisome Proliferator-Activated Receptors and the Control of Inflammation
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 1 Issue: 3 Year: 2002 Page: 243-248
Author(s): A. Cabrero, J. C. Laguna, M. Vazquez